眾安集團(00672.HK):眾安智慧最終發售價定於每股眾安智慧股份1.18港元
格隆匯7月17日丨眾安集團(00672.HK)發佈公吿,眾安智慧已將全球發售中眾安智慧股份的最終發售價定於每股眾安智慧股份1.18港元(不包括經紀佣金1.0%、證監會交易徵費0.0027%、聯交所交易費0.00565%及會計及財務彙報局交易徵費0.00015%)。
假設全球發售按照目前時間表完成,則(i)預期眾安智慧將於2023年7月18日在聯交所主板上市及(ii)預期眾安智慧股份將於2023年7月18日上午9時正於聯交所主板開始買賣。眾安智慧股份將以每手2,000股眾安智慧股份買賣,股份代號為2271。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.